5 minute read
Jun. 7, 2023

Difamilast is a Selective, Topical PDE4B Inhibitor Avoiding GI Side Effects

difamilast

topical PDE4 inhibitor marketed in Japan PDE4B subtype-selective inhibitor; discovery not disclosed JPET, April 11, 2023 Otsuka, Tokyo, JP

twitterlinkedinprintemail

MOTY Nominees

Molecule of the Year